CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly 's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter!

So, David Ricks, Lilly’s CEO, was understandably cautious. It was the latest in a string of milestone moments for the understated leader of the country’s most dynamic pharmaceutical company.

Eli Lilly stock booms April 17 Lilly's shares had increased roughly 16% by 1 p.m. ET after the results of the trial were released. Eli Lilly CEO David Ricks speaks during a press conference, on the ...

David Ricks, the CEO of Mounjaro and Zepbound maker Eli Lilly, explained why these medications are so expensive on the "In Good Company with Nicolai Tangen" podcast this week.

David Ricks has been with Eli Lilly since 1996 and was named chairman and CEO in 2017 after more than 20 years at the company. Now David joins me for a special episode of "Influencers" as we ...

The body language was encouraging. And the data, outlined in about 50 slides shown to Ricks and his team over the course of the hour, was clear: The pill, called orforglipron, was a success. For the ...